AMBOSS key facts
as of Oct 2026- Developer of a learning application designed to provide global access to a holistic platform for medical students.
- AMBOSS is valued at approximately $867.6M as of Oct 2026 (last reported valuation).
- It has raised $321.6M; the latest was Later Stage VC ($260.3M) in Apr 2025.
- Notable investors include Draper Associates, Partech, Cherry Ventures, Lightrock, Project A Ventures — 18 tracked in total.
- Status: Privately Held (backing).
AMBOSS's last reported valuation, Apr 2025. Nothing priced has surfaced since.
- ·The complete investor list: 18 names
- ·Watch AMBOSS: the Monday email on marks, rounds and moves
AMBOSS funding rounds
No funding rounds for AMBOSS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs AMBOSS
18+AMBOSS valuation
AMBOSS's last reported valuation was $868 million in Apr 2025. No priced round, secondary trade or fund mark has surfaced since.
AMBOSS investors
18 investors are on record for AMBOSS, including Draper Associates, Partech, Cherry Ventures and Lightrock. By type, the record holds 6 venture capital firms and 2 family offices.
About AMBOSS
Developer of a learning application designed to provide global access to a holistic platform for medical students. The company's application provides all the information on audited diseases, including drawings, pictures, and videos, along with a clinic database that offers suitable clinics, their specialist departments, important contact persons, and working conditions on-site, enabling medical students and professionals to get help in their studies, exams, and professional life.
- Sector
- Healthcare
- HQ
- Berlin, Germany
- Founded
- 2012
- Employees
- 500
- Website
- amboss.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.